These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21499794)

  • 21. Antiretroviral therapy, labor productivity, and sex: a longitudinal cohort study of tea pluckers in Kenya.
    Larson BA; Fox MP; Bii M; Rosen S; Rohr J; Shaffer D; Sawe F; Wasunna M; Simon JL
    AIDS; 2013 Jan; 27(1):115-23. PubMed ID: 23014516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poor quality of life among untreated Thai and Cambodian children without severe HIV symptoms.
    Bunupuradah T; Puthanakit T; Kosalaraksa P; Kerr SJ; Kariminia A; Hansudewechakul R; Kanjanavanit S; Ngampiyaskul C; Wongsawat J; Luesomboon W; Chuenyam T; Vonthanak S; Vun MC; Vibol U; Vannary B; Ruxrungtham K; Ananworanich J;
    AIDS Care; 2012; 24(1):30-8. PubMed ID: 21777076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
    PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
    Lifson AR; Grandits GA; Gardner EM; Wolff MJ; Pulik P; Williams I; Burman WJ;
    HIV Med; 2015 Apr; 16 Suppl 1(0 1):88-96. PubMed ID: 25711327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration.
    Gabillard D; Lewden C; Ndoye I; Moh R; Segeral O; Tonwe-Gold B; Etard JF; Pagnaroat M; Fournier-Nicolle I; Eholié S; Konate I; Minga A; Mpoudi-Ngole E; Koulla-Shiro S; Zannou DM; Anglaret X; Laurent C;
    J Acquir Immune Defic Syndr; 2013 Apr; 62(5):555-61. PubMed ID: 23274931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
    del Amo J; Moreno S; Bucher HC; Furrer H; Logan R; Sterne J; Pérez-Hoyos S; Jarrín I; Phillips A; Lodi S; van Sighem A; de Wolf W; Sabin C; Bansi L; Justice A; Goulet J; Miró JM; Ferrer E; Meyer L; Seng R; Toulomi G; Gargalianos P; Costagliola D; Abgrall S; Hernán MA;
    Clin Infect Dis; 2012 May; 54(9):1364-72. PubMed ID: 22460971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a lay health worker led group antiretroviral medication adherence training among non-adherent HIV-positive patients in KwaZulu-Natal, South Africa: results from a randomized trial.
    Peltzer K; Ramlagan S; Jones D; Weiss SM; Fomundam H; Chanetsa L
    SAHARA J; 2012 Nov; 9(4):218-26. PubMed ID: 23234350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When to start antiretroviral therapy in resource-limited settings.
    Walensky RP; Wolf LL; Wood R; Fofana MO; Freedberg KA; Martinson NA; Paltiel AD; Anglaret X; Weinstein MC; Losina E;
    Ann Intern Med; 2009 Aug; 151(3):157-66. PubMed ID: 19620143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social grants for people living with HIV and on antiretroviral therapy in KwaZulu-Natal, South Africa: a longitudinal study.
    Peltzer K
    SAHARA J; 2012; 9(1):6-14. PubMed ID: 23237016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of antiretroviral therapy on quality of life in HIV-infected Southeast Asian children in the PREDICT study.
    Bunupuradah T; Kosalaraksa P; Vibol U; Hansudewechakul R; Sophonphan J; Kanjanavanit S; Ngampiyaskul C; Wongsawat J; Luesomboon W; Vonthanak S; Ananworanich J; Ruxrungtham K; Puthanakit T;
    AIDS Patient Care STDS; 2013 Nov; 27(11):596-603. PubMed ID: 24191673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hospitalization trends, costs, and risk factors in HIV-infected children on antiretroviral therapy.
    Collins IJ; Cairns J; Jourdain G; Fregonese F; Nantarukchaikul M; Lertpienthum N; Wannarit P; Attavinijtrakarn P; Layangool P; Le Coeur S; Lallemant M;
    AIDS; 2012 Sep; 26(15):1943-52. PubMed ID: 22824633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.
    Kalayjian RC; Lau B; Mechekano RN; Crane HM; Rodriguez B; Salata RA; Krishnasami Z; Willig JH; Martin JN; Moore RD; Eron JJ; Kitahata MM
    AIDS; 2012 Sep; 26(15):1907-15. PubMed ID: 22824630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.
    Nichols SL; Bethel J; Kapogiannis BG; Li T; Woods SP; Patton ED; Ren W; Thornton SE; Major-Wilson HO; Puga AM; Sleasman JW; Rudy BJ; Wilson CM; Garvie PA;
    J Neurovirol; 2016 Apr; 22(2):218-30. PubMed ID: 26463526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis.
    Nachega JB; Uthman OA; Anderson J; Peltzer K; Wampold S; Cotton MF; Mills EJ; Ho YS; Stringer JS; McIntyre JA; Mofenson LM
    AIDS; 2012 Oct; 26(16):2039-52. PubMed ID: 22951634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection.
    Nieuwkerk PT; Gisolf EH; Reijers MH; Lange JM; Danner SA; Sprangers MA; ; ;
    AIDS; 2001 Oct; 15(15):1985-91. PubMed ID: 11600827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
    Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
    Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.